Phibro Animal Health PAHC Ratios & Valuation
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 32.5%+0.9pp | 31.9%+0.1pp | 31.2%-0.3pp | 30.9%+0.1pp | 31.7%+1.4pp | |
| Operating margin | 12%+4.0pp | 11.5%+4.2pp | 10.3%+3.4pp | 8.5%+3.3pp | 8%+2.1pp | |
| Net margin | 6.3%+3.7pp | 6.3%+4.5pp | 4.8%+3.2pp | 3.7%+3.5pp | 2.7%+1.4pp | |
| EBITDA margin | 15.4%+3.8pp | 15%+4.1pp | 13.8%+3.5pp | 12%+3.2pp | 11.6%+2.1pp | |
| Free cash flow margin | 0.9%-3.3pp | 3.2%— | 2.4%— | 3.2%— | 4.1%— | |
| Returns | ||||||
| Return on equity | 30.3%+18.5pp | 31.8%+24.3pp | 23.8%+17.2pp | 17.8%+16.9pp | 11.9%+7.0pp | |
| Return on assets | 6.9%+4.1pp | 6.8%+5.1pp | 5.8%+4.0pp | 4.1%+3.9pp | 2.8%+1.4pp | |
| Return on invested capital | 46.7%+20.6pp | 48.3%+28.6pp | 42.3%+26.3pp | 29.6%+19.9pp | 26%+13.8pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×0.0× | 1.1×+0.1× | 1.2×+0.1× | 1.1×+0.1× | 1×0.0× | |
| Inventory turnover | 2×-0.2× | 2.1×0.0× | 2.6×0.0× | 2.5×-0.1× | 2.2×-0.2× | |
| Liquidity | ||||||
| Current ratio | 3.2×+0.3× | 3.1×-0.1× | 3.1×-0.1× | 2.8×-0.2× | 2.9×-0.2× | |
| Quick ratio | 1.3×0.0× | 1.2×-0.1× | 1.3×-0.3× | 1.2×-0.4× | 1.2×-0.4× | |
| Cash ratio | 0.2×0.0× | 0.2×-0.1× | 0.3×0.0× | 0.2×-0.1× | 0.2×0.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.2×-0.1× | 0.1×+0.1× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -0.1×+0.2× | -0.1×+0.2× | -0.2×+0.1× | -0.1×0.0× | -0.3×+0.2× | |
| Per Share | ||||||
| Book value per share | $8.82+34.9% | $8.12+33.9% | $7.62+19.7% | $7.02+10.9% | $6.53-2.0% | |
| Valuation | ||||||
| Market capitalization | $1.27B+31.4% | $1.51B+78.0% | $1.64B+79.8% | $1B+47.8% | $865.16M+65.2% | |
| Enterprise value | $1.25B+33.9% | $1.49B+84.3% | $1.59B+82.1% | $995.1M+47.2% | $830.04M+72.0% | |
| Price / earnings | 13.4×-17.1× | 16.4×-27.6× | 24.2×-28.2× | 20.8×-260× | 27.2×-12.6× | |
| Price / sales | 0.9×0.0× | 1×+0.3× | 1.2×+0.3× | 0.8×+0.1× | 0.7×+0.2× | |
| Price / book | 3.5×-0.1× | 4.6×+1.1× | 5.3×+1.7× | 3.5×+0.9× | 3.3×+1.3× | |
| EV / EBITDA | 5.4×-1.4× | 6.8×+0.1× | 8.2×+0.1× | 6.4×-1.2× | 6×+0.9× | |
| EV / sales | 0.8×0.0× | 1×+0.3× | 1.1×+0.3× | 0.8×+0.1× | 0.7×+0.2× | |
| Free cash flow yield | 1%-4.1pp | 3.1%— | 2.1%— | 4.2%— | 5.7%— | |
| Earnings yield | 7.5%+4.2pp | 6.1%+3.8pp | 4.1%+2.2pp | 4.8%+4.5pp | 3.7%+1.2pp | |
| Dividend yield | 1.5%-0.5pp | 1.3%-1.0pp | 1.2%-0.9pp | 1.9%-0.9pp | 2.2%-1.5pp | |
| PEG ratio | 0.1×-0.1× | 0×— | 0.1×— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Phibro Animal Health's profit margins?
- Phibro Animal Health (PAHC) runs a 32.5% gross margin and a 12.0% operating margin, with a 6.3% net margin.
- Where do Phibro Animal Health's ratios come from?
- Every ratio is computed from Phibro Animal Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
